The risk of short OS in the ΔsADC positive group was lower than that in the ΔsADC non-positive group, except for the subgroups of age ≥ 60, female, PD-L1 usage, tumor number > 3, without PVTT, BCLC-B stage, ECOG PS ≥ 1, no HBV infection, and AFP < 400 ng/mL (Fig. S11). Here, AFP is linked to neoplasm.